Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.63% on an annualized basis producing an average annual return of 10.11%. Currently, Biogen has a market capitalization of $31.20 billion.
Buying $100 In BIIB: If an investor had bought $100 of BIIB stock 15 years ago, it would be worth $430.05 today based on a price of $213.03 for BIIB at the time of writing.
Biogen's Performance Over Last 15 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
